13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-02-26 Event 2024-09-12 SEC 0002007919-25-000012 →

Lappe Mark Inhibrx Biosciences, Inc. INBX

Stake: 6.40% Shares: 925,413 CUSIP: 45720N103 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 8.58
2,119,421 shares short · +13.7% vs prior

Other 13D/G Filings on Inhibrx Biosciences, Inc.

FiledFormFilerStakeShares
2025-02-26 SCHEDULE Kayyem Jon Faiz 7.90% 1,149,046 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →